Immunomodulating Hydrogels as Stealth Platform for Drug Delivery Applications

Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including cancer and arthritis. Therefore, non-toxic materials that do not trigger an immunogenic response during delivery are crucial for safe and effect...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 14; no. 10; p. 2244
Main Authors Rezaei, Zahra, Yilmaz-Aykut, Dilara, Tourk, Fatima Mumtaza, Bassous, Nicole, Barroso-Zuppa, Margot, Shawl, Asif Iqbal, Ashraf, Syed Salman, Avci, Huseyin, Hassan, Shabir
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 01.10.2022
MDPI
Subjects
Antimitotic agents
Antineoplastic agents
Arthritis
Biodegradable materials
biomaterials
Biomedical materials
Cancer therapies
Chemical properties
Colloids
Cytokines
Diabetes
Dosage and administration
Drug delivery systems
Drugs
Fibroblasts
Foreign bodies
foreign body response
Genotype & phenotype
Glucose
Growth factors
Health aspects
Hydrogels
immune modulation
Immunotherapy
Inflammation
Insulin
Nanoparticles
Osteoarthritis
Pharmaceutical research
Regenerative medicine
Review
Tissue engineering
Transplants & implants
Vehicles
United Arab Emirates
Online AccessGet full text

Cover

Abstract Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including cancer and arthritis. Therefore, non-toxic materials that do not trigger an immunogenic response during delivery are crucial for safe and effective in vivo treatment. Hydrogels are excellent candidates that can be engineered to control immune responses by modulating biomolecule release/adsorption, improving regeneration of lymphoid tissues, and enhancing function during antigen presentation. This review discusses the aspects of hydrogel-based systems used as drug delivery platforms for various diseases. A detailed investigation on different immunomodulation strategies for various delivery options and deliberate upon the outlook of such drug delivery platforms are conducted.
AbstractList Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including cancer and arthritis. Therefore, non-toxic materials that do not trigger an immunogenic response during delivery are crucial for safe and effective in vivo treatment. Hydrogels are excellent candidates that can be engineered to control immune responses by modulating biomolecule release/adsorption, improving regeneration of lymphoid tissues, and enhancing function during antigen presentation. This review discusses the aspects of hydrogel-based systems used as drug delivery platforms for various diseases. A detailed investigation on different immunomodulation strategies for various delivery options and deliberate upon the outlook of such drug delivery platforms are conducted.Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including cancer and arthritis. Therefore, non-toxic materials that do not trigger an immunogenic response during delivery are crucial for safe and effective in vivo treatment. Hydrogels are excellent candidates that can be engineered to control immune responses by modulating biomolecule release/adsorption, improving regeneration of lymphoid tissues, and enhancing function during antigen presentation. This review discusses the aspects of hydrogel-based systems used as drug delivery platforms for various diseases. A detailed investigation on different immunomodulation strategies for various delivery options and deliberate upon the outlook of such drug delivery platforms are conducted.
Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including cancer and arthritis. Therefore, non-toxic materials that do not trigger an immunogenic response during delivery are crucial for safe and effective in vivo treatment. Hydrogels are excellent candidates that can be engineered to control immune responses by modulating biomolecule release/adsorption, improving regeneration of lymphoid tissues, and enhancing function during antigen presentation. This review discusses the aspects of hydrogel-based systems used as drug delivery platforms for various diseases. A detailed investigation on different immunomodulation strategies for various delivery options and deliberate upon the outlook of such drug delivery platforms are conducted.
Audience Academic
Author Ashraf, Syed Salman
Bassous, Nicole
Hassan, Shabir
Rezaei, Zahra
Yilmaz-Aykut, Dilara
Barroso-Zuppa, Margot
Tourk, Fatima Mumtaza
Shawl, Asif Iqbal
Avci, Huseyin
AuthorAffiliation 8 Center for Catalysis and Separation (CeCas), SAN Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
11 Cellular Therapy and Stem Cell Research Center, Eskisehir Osmangazi University, 26040 Eskisehir, Turkey
2 Chemical Engineering Department, Sharif University of Technology, Azadi Ave, Tehran 11365-11155, Iran
12 Translational Medicine Research and Clinical Center, Eskisehir Osmangazi University, 26040 Eskisehir, Turkey
5 School of Medicine and Health Sciences, Tecnologico de Monterrey, Mexico City 14380, Mexico
7 Center for Biotechnology (BTC), Main Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
9 Advanced Materials Chemistry Centre (AMCC), SAN Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
1 Division of Engineering in Medicine, Brigham and Women’s Hospital, Department of Medicine, Harvard Medical School, Cambridge, MA 02139, USA
3 Department of Chemical Engineering, Faculty of Engineering, Istanbul University
AuthorAffiliation_xml – name: 2 Chemical Engineering Department, Sharif University of Technology, Azadi Ave, Tehran 11365-11155, Iran
– name: 11 Cellular Therapy and Stem Cell Research Center, Eskisehir Osmangazi University, 26040 Eskisehir, Turkey
– name: 9 Advanced Materials Chemistry Centre (AMCC), SAN Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
– name: 8 Center for Catalysis and Separation (CeCas), SAN Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
– name: 10 Department of Metallurgical and Materials Engineering, Eskisehir Osmangazi University, 26040 Eskisehir, Turkey
– name: 1 Division of Engineering in Medicine, Brigham and Women’s Hospital, Department of Medicine, Harvard Medical School, Cambridge, MA 02139, USA
– name: 4 Department of Mechanical Engineering, Northeastern University, Boston, MA 02115, USA
– name: 3 Department of Chemical Engineering, Faculty of Engineering, Istanbul University-Cerrahpaşa, 34320 Istanbul, Turkey
– name: 5 School of Medicine and Health Sciences, Tecnologico de Monterrey, Mexico City 14380, Mexico
– name: 12 Translational Medicine Research and Clinical Center, Eskisehir Osmangazi University, 26040 Eskisehir, Turkey
– name: 6 Department of Biology, College of Arts and Sciences, Main Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
– name: 7 Center for Biotechnology (BTC), Main Campus, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates
Author_xml – sequence: 1
  givenname: Zahra
  surname: Rezaei
  fullname: Rezaei, Zahra
– sequence: 2
  givenname: Dilara
  orcidid: 0000-0002-2287-2585
  surname: Yilmaz-Aykut
  fullname: Yilmaz-Aykut, Dilara
– sequence: 3
  givenname: Fatima Mumtaza
  surname: Tourk
  fullname: Tourk, Fatima Mumtaza
– sequence: 4
  givenname: Nicole
  surname: Bassous
  fullname: Bassous, Nicole
– sequence: 5
  givenname: Margot
  orcidid: 0000-0001-6211-3367
  surname: Barroso-Zuppa
  fullname: Barroso-Zuppa, Margot
– sequence: 6
  givenname: Asif Iqbal
  surname: Shawl
  fullname: Shawl, Asif Iqbal
– sequence: 7
  givenname: Syed Salman
  orcidid: 0000-0003-4961-5527
  surname: Ashraf
  fullname: Ashraf, Syed Salman
– sequence: 8
  givenname: Huseyin
  orcidid: 0000-0002-2475-1963
  surname: Avci
  fullname: Avci, Huseyin
– sequence: 9
  givenname: Shabir
  orcidid: 0000-0002-5822-9508
  surname: Hassan
  fullname: Hassan, Shabir
BookMark eNp9km9rFDEQxhepYK39CMKCb3xzNX93NwjC0ao9qCior8NcdrKXI7tZk93CfXtzvUp7pZhAEmae3xMymdfFyRAGLIq3lFxwrsiHcQOxB4Pz5EyighLGhHhRnFKl1EIoxk8enV8V5yltSR6c04ar0-Lbqu_nIfShnT1MbujK610bQ4c-lZDKnxOCnzblj5y0IfZlXsqrOHflFXp3i3FXLsfRO5PZMKQ3xUsLPuH5_X5W_P7y-dfl9eLm-9fV5fJmYaRQ08LahiFXVjFAwHZNa0kNABeSM06rFqxoqWx4DU3Na1MTJHLdtkKyilTALT8rVgffNsBWj9H1EHc6gNN3gRA7DTEXxKOWTWUsKgFEScHRKqnWSKyVaEmtkGevTwevcV732Bocpgj-yPQ4M7iN7sKtVhUltJLZ4P29QQx_ZkyT7l0y6D0MGOakWc2UpI1ie-m7J9JtmOOQS7VXNZIRRdWDqoP8ADfYkO81e1O9rEXFa0FrklUXz6jybLF3JjeJdTl-BHw8ACaGlCJabdx0928ZdF5TovcdpZ_tqEzLJ_S_Cv2f-wsiZtbP
CitedBy_id crossref_primary_10_1016_j_biomaterials_2025_123274
crossref_primary_10_1208_s12249_024_02843_5
crossref_primary_10_1021_acsomega_3c08326
crossref_primary_10_1039_D3TB02626D
crossref_primary_10_3389_fimmu_2024_1387945
crossref_primary_10_1016_j_ijbiomac_2025_139551
crossref_primary_10_1016_j_addr_2024_115395
crossref_primary_10_3390_gels11010007
crossref_primary_10_1002_adtp_202300002
crossref_primary_10_1016_j_addr_2024_115429
crossref_primary_10_1063_5_0228692
crossref_primary_10_37349_ebmx_2025_101332
Cites_doi 10.1021/acs.analchem.6b04251
10.1016/S0076-6879(06)20019-3
10.3389/fcimb.2020.00008
10.1021/acsbiomaterials.6b00706
10.1021/acsbiomaterials.0c00443
10.4049/jimmunol.1401776
10.1016/j.carbpol.2022.119336
10.1126/sciadv.abd7600
10.1038/s41578-020-0209-x
10.1016/j.addr.2017.05.013
10.1056/NEJMoa1902226
10.1146/annurev-med-092012-112807
10.1002/jbm.b.34921
10.1016/j.actbio.2019.02.016
10.1002/jbm.a.36890
10.1016/j.addr.2018.04.008
10.3389/fbioe.2020.00542
10.2147/IJN.S189587
10.1016/j.ymthe.2018.07.022
10.1016/j.biomaterials.2021.121272
10.1007/978-1-4419-1601-3_8
10.1002/mabi.202200043
10.1038/s41565-021-00931-2
10.1016/j.biomaterials.2020.120216
10.1038/s41568-019-0186-9
10.3390/molecules24030603
10.1002/btm2.10063
10.1016/j.biomaterials.2020.120608
10.1021/acsnano.7b07082
10.1021/jacs.1c07492
10.1016/j.cej.2021.132664
10.3389/fphar.2014.00123
10.3389/fendo.2021.716692
10.1111/anu.12929
10.1038/s12276-018-0191-1
10.1001/jamanetworkopen.2021.18811
10.1002/adhm.201600316
10.1016/j.addr.2021.01.011
10.1002/cnma.202100062
10.3389/fbioe.2020.00292
10.1177/1758834014567470
10.18632/oncotarget.24832
10.1016/j.msec.2020.111096
10.1056/NEJMoa1703327
10.1002/jbm.a.31221
10.1177/193229680900300213
10.1097/MOT.0000000000000130
10.1073/pnas.142298299
10.1002/adfm.202105967
10.1038/s41598-019-42349-w
10.1016/S0952-7915(96)80125-7
10.1073/pnas.162124199
10.1002/adma.202100176
10.4049/jimmunol.174.5.3006
10.1016/j.biomaterials.2020.119841
10.1002/smll.201902232
10.1016/j.mtbio.2021.100139
10.3839/jabc.2018.049
10.1002/adhm.202001239
10.1016/j.jconrel.2017.04.011
10.1002/advs.202003599
10.1073/pnas.1305569110
10.1002/adhm.201801578
10.1021/acs.langmuir.8b01834
10.3390/cells9020419
10.1016/j.biomaterials.2019.119403
10.1038/s42003-019-0642-9
10.4049/jimmunol.175.5.3309
10.1016/S1471-4906(03)00207-2
10.1038/s41563-019-0462-9
10.1016/j.biomaterials.2020.120549
10.1109/TBME.2014.2305753
10.1038/nmat4290
10.3390/molecules25071539
10.1016/j.jconrel.2015.08.014
10.1111/imm.12972
10.1016/j.actbio.2021.01.041
10.3389/fcvm.2019.00026
10.4018/978-1-7998-1604-1
10.1016/j.it.2006.08.002
10.1016/j.tibtech.2016.03.009
10.1016/S0140-6736(11)60895-7
10.1016/j.nantod.2020.101049
10.1016/j.biomaterials.2009.05.083
10.1002/adma.201402105
10.7150/thno.39167
10.3389/fimmu.2017.01676
10.1002/adfm.201902581
10.2215/CJN.03510807
10.3390/membranes11090702
10.1016/j.clcc.2019.06.004
10.1016/j.addr.2015.10.020
10.1160/TH05-07-0492
10.1016/j.biomaterials.2010.01.035
10.1016/j.apmt.2018.11.013
10.1186/s12951-022-01414-9
10.3390/ijms21051598
10.1038/s41578-019-0106-3
10.1080/21645515.2015.1129478
10.4049/jimmunol.1701172
10.2174/1381612823666170214120708
10.1021/acs.chemrev.0c00895
10.1089/ten.teb.2019.0131
10.7150/thno.38425
10.1038/s41563-018-0077-6
10.1038/natrevmats.2016.40
10.1039/C9RA02878A
10.1186/s13045-019-0817-3
10.1007/s13238-017-0412-8
10.1089/ten.tea.2012.0643
10.1155/2020/8868618
10.1016/j.actbio.2019.04.049
10.1186/1741-7007-10-7
10.1126/sciadv.abd8056
10.2139/ssrn.3708588
10.1021/acsbiomaterials.9b01550
10.1016/j.apmt.2020.100608
10.1002/jgm.3415
10.1196/annals.1375.052
10.34091/AJLS.4.1.12
10.1002/adfm.201902785
10.1038/nbt.2434
10.1002/anbr.202000073
10.1016/j.molmed.2020.03.009
ContentType Journal Article
Copyright COPYRIGHT 2022 MDPI AG
2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: COPYRIGHT 2022 MDPI AG
– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/pharmaceutics14102244
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
ProQuest Central Student
Research Library Prep
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic



CrossRef
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1999-4923
ExternalDocumentID oai_doaj_org_article_586cfe94a09543ef959be0ff5ef079e3
PMC9610165
A746374170
10_3390_pharmaceutics14102244
GeographicLocations United Arab Emirates
GeographicLocations_xml – name: United Arab Emirates
GrantInformation_xml – fundername: Khalifa University
  grantid: FSU 8474000442; FSU-2022-022
GroupedDBID ---
53G
5VS
8G5
AADQD
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACUHS
AEAQA
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
F5P
FD6
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
TR2
TUS
PMFND
3V.
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c549t-ff82e39f92aeaedb1751caa34532316daf4d15837a8737c70e05bdd452606a3f3
IEDL.DBID M48
ISSN 1999-4923
IngestDate Wed Aug 27 01:32:06 EDT 2025
Thu Aug 21 18:38:43 EDT 2025
Fri Jul 11 15:27:30 EDT 2025
Mon Jun 30 12:39:15 EDT 2025
Tue Jun 17 22:21:01 EDT 2025
Tue Jun 10 21:19:12 EDT 2025
Tue Jul 01 03:36:18 EDT 2025
Thu Apr 24 22:55:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-ff82e39f92aeaedb1751caa34532316daf4d15837a8737c70e05bdd452606a3f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-5822-9508
0000-0002-2475-1963
0000-0001-6211-3367
0000-0002-2287-2585
0000-0003-4961-5527
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/pharmaceutics14102244
PQID 2728520919
PQPubID 2032349
ParticipantIDs doaj_primary_oai_doaj_org_article_586cfe94a09543ef959be0ff5ef079e3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9610165
proquest_miscellaneous_2729518925
proquest_journals_2728520919
gale_infotracmisc_A746374170
gale_infotracacademiconefile_A746374170
crossref_citationtrail_10_3390_pharmaceutics14102244
crossref_primary_10_3390_pharmaceutics14102244
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-10-01
PublicationDateYYYYMMDD 2022-10-01
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Pharmaceutics
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Hooshmand (ref_4) 2022; 24
Ashoori (ref_6) 2020; 2020
Wherrett (ref_108) 2011; 378
Wei (ref_10) 2019; 14
Chen (ref_111) 2021; 4
Zhu (ref_25) 2020; 256
Abbas (ref_82) 1996; 8
Paris (ref_32) 2021; 7
Huang (ref_57) 2020; 6
Uehara (ref_61) 2019; 9
Herrmann (ref_3) 2021; 16
Brodbeck (ref_84) 2002; 99
ref_125
Ji (ref_64) 2020; 10
Szymczak (ref_100) 2021; 7
Floudas (ref_97) 2019; 18
Li (ref_19) 2021; 1
Wu (ref_37) 2017; 255
Elsherif (ref_41) 2018; 12
Han (ref_63) 2019; 220
ref_24
Ren (ref_39) 2021; 124
Saghazadeh (ref_5) 2018; 127
ref_124
Mei (ref_102) 2022; 20
Clayton (ref_74) 2017; 8
Jo (ref_110) 2021; 1019
Andorko (ref_80) 2017; 2
Wang (ref_96) 2019; 2
Whitaker (ref_120) 2021; 121
Chen (ref_122) 2021; 269
Tan (ref_98) 2018; 9
Goldberg (ref_16) 2019; 19
Drukker (ref_77) 2006; 420
ref_72
Lv (ref_31) 2018; 3
Ouwens (ref_112) 2020; 19
Gribova (ref_113) 2022; 22
Stojanovic (ref_65) 2017; 23
Sullivan (ref_105) 2018; 378
Chao (ref_17) 2020; 30
Ogle (ref_21) 2017; 4
Yan (ref_34) 2019; 29
Soto (ref_42) 2017; 89
Leach (ref_127) 2019; 88
Yang (ref_62) 2020; 19
Liu (ref_43) 2021; 8
Fan (ref_119) 2021; 143
Veiseh (ref_86) 2015; 14
Nishiguchi (ref_58) 2020; 108
Yi (ref_50) 2020; 8
Kendall (ref_33) 2014; 5
Getts (ref_70) 2012; 30
Dumont (ref_66) 2015; 219
Gaharwar (ref_15) 2020; 5
Singh (ref_11) 2014; 26
Darvin (ref_93) 2018; 50
Shi (ref_44) 2018; 35
Lin (ref_18) 2009; 30
Vishwakarma (ref_20) 2016; 34
Pravda (ref_101) 2019; 9
Hymel (ref_13) 2022; 8
Dellacherie (ref_71) 2019; 4
Liu (ref_73) 2020; 10
Fallon (ref_114) 2006; 27
Vey (ref_99) 2018; 9
Sundar (ref_95) 2015; 7
He (ref_38) 2022; 280
Drukker (ref_78) 2002; 99
Saleh (ref_121) 2019; 15
Bloise (ref_56) 2020; 8
Muthuramalingam (ref_53) 2018; 61
Pravda (ref_54) 2016; 5
Sundblad (ref_76) 2017; 199
Northrup (ref_90) 2016; 98
Cecen (ref_7) 2021; 36
McCoy (ref_118) 2005; 174
Page (ref_92) 2014; 65
Youngblood (ref_46) 2018; 26
ref_60
Jin (ref_26) 2020; 115
Kharbikar (ref_40) 2021; 174
Hume (ref_83) 2010; 31
Yan (ref_51) 2021; 31
Graham (ref_75) 2013; 19
Srinivas (ref_67) 2008; 3
Lee (ref_2) 2020; 19
Qasim (ref_14) 2019; 14
Krzystyniak (ref_68) 2014; 19
Adisakwattana (ref_115) 2009; 666
Ferrini (ref_9) 2019; 6
Gosselin (ref_52) 2018; 17
Tomlin (ref_89) 2018; 155
Nam (ref_30) 2019; 91
Lim (ref_1) 2019; 9
Cai (ref_36) 2021; 10
Pai (ref_12) 2014; 61
Reyshari (ref_59) 2019; 25
Ludvigsson (ref_103) 2009; 3
Viswanathan (ref_117) 2006; 95
Savoia (ref_94) 2016; 12
Huang (ref_22) 2020; 6
Chen (ref_81) 2019; 25
Mullick (ref_116) 2003; 24
Yang (ref_27) 2021; 12
Jones (ref_85) 2007; 83
Herold (ref_104) 2019; 381
Zhao (ref_126) 2019; 12
Rocchi (ref_23) 2020; 26
Wang (ref_29) 2022; 430
Rowley (ref_87) 2019; 8
Nicholas (ref_109) 2011; 11
Barthes (ref_55) 2021; 268
ref_106
ref_47
Heydari (ref_88) 2022; 110
Obermajer (ref_69) 2014; 193
Tseng (ref_35) 2013; 110
Hao (ref_45) 2022; 287
Sadtler (ref_79) 2016; 1
Elias (ref_107) 2006; 1079
Inam (ref_28) 2021; 4
Dai (ref_8) 2020; 240
Stewart (ref_48) 2017; 114
ref_49
Ko (ref_91) 2005; 175
Kharaziha (ref_123) 2021; 33
References_xml – volume: 89
  start-page: 276
  year: 2017
  ident: ref_42
  article-title: In vivo chemical sensors: Role of biocompatibility on performance and utility
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.6b04251
– volume: 420
  start-page: 391
  year: 2006
  ident: ref_77
  article-title: Immunogenicity of embryonic stem cells and their progeny
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(06)20019-3
– volume: 10
  start-page: 8
  year: 2020
  ident: ref_73
  article-title: Kupffer cells: Important participant of hepatic alveolar echinococcosis
  publication-title: Front. Cell. Infect. Microbiol.
  doi: 10.3389/fcimb.2020.00008
– volume: 19
  start-page: 334
  year: 2020
  ident: ref_112
  article-title: The small chain fatty acid butyrate antagonizes the TCR-stimulation-induced metabolic shift in murine epidermal gamma delta T cells
  publication-title: EXCLI J.
– volume: 4
  start-page: 1241
  year: 2017
  ident: ref_21
  article-title: Dual affinity heparin-based hydrogels achieve pro-regenerative immunomodulation and microvascular remodeling
  publication-title: ACS Biomater. Sci. Eng.
  doi: 10.1021/acsbiomaterials.6b00706
– volume: 11
  start-page: 293
  year: 2011
  ident: ref_109
  article-title: Autoantigen based vaccines for type 1 diabetes
  publication-title: Discov. Med.
– volume: 6
  start-page: 3270
  year: 2020
  ident: ref_57
  article-title: Biomimetic gelatin methacrylate/nano fish bone hybrid hydrogel for bone regeneration via osteoimmunomodulation
  publication-title: ACS Biomater. Sci. Eng.
  doi: 10.1021/acsbiomaterials.0c00443
– volume: 193
  start-page: 4988
  year: 2014
  ident: ref_69
  article-title: Conversion of Th17 into IL-17Aneg regulatory T cells: A novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell–supported minimized immunosuppressive therapy
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1401776
– volume: 287
  start-page: 119336
  year: 2022
  ident: ref_45
  article-title: Carboxymethyl chitosan-based hydrogels containing fibroblast growth factors for triggering diabetic wound healing
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2022.119336
– volume: 7
  start-page: eabd7600
  year: 2021
  ident: ref_100
  article-title: Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abd7600
– volume: 5
  start-page: 686
  year: 2020
  ident: ref_15
  article-title: Engineered biomaterials for in situ tissue regeneration
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/s41578-020-0209-x
– volume: 114
  start-page: 161
  year: 2017
  ident: ref_48
  article-title: Combinatorial drug delivery approaches for immunomodulation
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2017.05.013
– volume: 381
  start-page: 603
  year: 2019
  ident: ref_104
  article-title: An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1902226
– volume: 65
  start-page: 185
  year: 2014
  ident: ref_92
  article-title: Immune modulation in cancer with antibodies
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev-med-092012-112807
– volume: 110
  start-page: 265
  year: 2022
  ident: ref_88
  article-title: Current knowledge of immunomodulation strategies for chronic skin wound repair
  publication-title: J. Biomed. Mater. Res. Part B Appl. Biomater.
  doi: 10.1002/jbm.b.34921
– volume: 88
  start-page: 15
  year: 2019
  ident: ref_127
  article-title: Advances in immunotherapy delivery from implantable and injectable biomaterials
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2019.02.016
– volume: 108
  start-page: 1159
  year: 2020
  ident: ref_58
  article-title: Sustained-immunostimulatory nanocellulose scaffold to enhance vaccine efficacy
  publication-title: J. Biomed. Mater. Res. Part A
  doi: 10.1002/jbm.a.36890
– volume: 127
  start-page: 138
  year: 2018
  ident: ref_5
  article-title: Drug delivery systems and materials for wound healing applications
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2018.04.008
– volume: 8
  start-page: 542
  year: 2020
  ident: ref_50
  article-title: An injectable hydrogel platform for sustained delivery of anti-inflammatory nanocarriers and induction of regulatory T cells in atherosclerosis
  publication-title: Front. Bioeng. Biotechnol.
  doi: 10.3389/fbioe.2020.00542
– volume: 14
  start-page: 1311
  year: 2019
  ident: ref_14
  article-title: 3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration
  publication-title: Int. J. Nanomed.
  doi: 10.2147/IJN.S189587
– volume: 26
  start-page: 2087
  year: 2018
  ident: ref_46
  article-title: It’s all in the delivery: Designing hydrogels for cell and non-viral gene therapies
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2018.07.022
– volume: 280
  start-page: 121272
  year: 2022
  ident: ref_38
  article-title: Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd single atom nanozymes as a localized immunomodulation niche for cancer catalytic immunotherapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2021.121272
– volume: 666
  start-page: 95
  year: 2009
  ident: ref_115
  article-title: Helminth-derived immunomodulatory molecules
  publication-title: Pathog.-Deriv. Immunomodulatory Mol.
  doi: 10.1007/978-1-4419-1601-3_8
– volume: 22
  start-page: 2200043
  year: 2022
  ident: ref_113
  article-title: Polyarginine as a Simultaneous Antimicrobial, Immunomodulatory, and miRNA Delivery Agent within Polyanionic Hydrogel
  publication-title: Macromol. Biosci.
  doi: 10.1002/mabi.202200043
– volume: 16
  start-page: 748
  year: 2021
  ident: ref_3
  article-title: Extracellular vesicles as a next-generation drug delivery platform
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-021-00931-2
– volume: 256
  start-page: 120216
  year: 2020
  ident: ref_25
  article-title: Modulation of macrophages by bioactive glass/sodium alginate hydrogel is crucial in skin regeneration enhancement
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.120216
– volume: 19
  start-page: 587
  year: 2019
  ident: ref_16
  article-title: Improving cancer immunotherapy through nanotechnology
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0186-9
– ident: ref_49
  doi: 10.3390/molecules24030603
– volume: 2
  start-page: 139
  year: 2017
  ident: ref_80
  article-title: Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine
  publication-title: Bioeng. Transl. Med.
  doi: 10.1002/btm2.10063
– volume: 269
  start-page: 120608
  year: 2021
  ident: ref_122
  article-title: Cryogel/hydrogel biomaterials and acupuncture combined to promote diabetic skin wound healing through immunomodulation
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.120608
– volume: 12
  start-page: 2283
  year: 2018
  ident: ref_41
  article-title: Glucose sensing with phenylboronic acid functionalized hydrogel-based optical diffusers
  publication-title: ACS Nano
  doi: 10.1021/acsnano.7b07082
– volume: 143
  start-page: 17180
  year: 2021
  ident: ref_119
  article-title: Dendritic Hydrogels Induce Immune Modulation in Human Keratinocytes and Effectively Eradicate Bacterial Pathogens
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.1c07492
– volume: 430
  start-page: 132664
  year: 2022
  ident: ref_29
  article-title: Exosomes laden self-healing injectable hydrogel enhances diabetic wound healing via regulating macrophage polarization to accelerate angiogenesis
  publication-title: Chem. Eng. J.
  doi: 10.1016/j.cej.2021.132664
– volume: 5
  start-page: 123
  year: 2014
  ident: ref_33
  article-title: Fibroblasts in fibrosis: Novel roles and mediators
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2014.00123
– volume: 1019
  start-page: 716692
  year: 2021
  ident: ref_110
  article-title: Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
  publication-title: Front. Endocrinol.
  doi: 10.3389/fendo.2021.716692
– volume: 25
  start-page: 1135
  year: 2019
  ident: ref_59
  article-title: Effects of sodium diformate on growth performance, gut microflora, digestive enzymes and innate immunological parameters of Asian sea bass (Lates calcarifer) juveniles
  publication-title: Aquac. Nutr.
  doi: 10.1111/anu.12929
– volume: 50
  start-page: 1
  year: 2018
  ident: ref_93
  article-title: Immune checkpoint inhibitors: Recent progress and potential biomarkers
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-018-0191-1
– volume: 4
  start-page: e2118811
  year: 2021
  ident: ref_111
  article-title: Association of Insulin Resistance and Type 2 Diabetes with Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies
  publication-title: JAMA Netw. Open
  doi: 10.1001/jamanetworkopen.2021.18811
– volume: 5
  start-page: 2841
  year: 2016
  ident: ref_54
  article-title: Hyaluronic acid and its derivatives in coating and delivery systems: Applications in tissue engineering, regenerative medicine and immunomodulation
  publication-title: Adv. Healthc. Mater.
  doi: 10.1002/adhm.201600316
– volume: 174
  start-page: 87
  year: 2021
  ident: ref_40
  article-title: Modulating the foreign body response of implants for diabetes treatment
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2021.01.011
– volume: 7
  start-page: 773
  year: 2021
  ident: ref_32
  article-title: Nano-and Microscale Drug Delivery Approaches for Therapeutic Immunomodulation
  publication-title: ChemNanoMat
  doi: 10.1002/cnma.202100062
– volume: 8
  start-page: 292
  year: 2020
  ident: ref_56
  article-title: Engineering immunomodulatory biomaterials for regenerating the infarcted myocardium
  publication-title: Front. Bioeng. Biotechnol.
  doi: 10.3389/fbioe.2020.00292
– volume: 7
  start-page: 85
  year: 2015
  ident: ref_95
  article-title: Nivolumab in NSCLC: Latest evidence and clinical potential
  publication-title: Ther. Adv. Med. Oncol.
  doi: 10.1177/1758834014567470
– volume: 9
  start-page: 17675
  year: 2018
  ident: ref_99
  article-title: A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D.; IPH2102) in patients with solid tumors and hematologic malignancies
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24832
– volume: 115
  start-page: 111096
  year: 2020
  ident: ref_26
  article-title: Injectable anti-inflammatory hyaluronic acid hydrogel for osteoarthritic cartilage repair
  publication-title: Mater. Sci. Eng. C
  doi: 10.1016/j.msec.2020.111096
– volume: 378
  start-page: 35
  year: 2018
  ident: ref_105
  article-title: Myeloablative autologous stem-cell transplantation for severe scleroderma
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1703327
– volume: 83
  start-page: 585
  year: 2007
  ident: ref_85
  article-title: Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells
  publication-title: J. Biomed. Mater. Res. Part A Off. J. Soc. Biomater.
  doi: 10.1002/jbm.a.31221
– volume: 3
  start-page: 320
  year: 2009
  ident: ref_103
  article-title: The role of immunomodulation therapy in autoimmune diabetes
  publication-title: J. Diabetes Sci. Technol.
  doi: 10.1177/193229680900300213
– volume: 19
  start-page: 610
  year: 2014
  ident: ref_68
  article-title: Islet cell transplant and the incorporation of Tregs
  publication-title: Curr. Opin. Organ Transplant.
  doi: 10.1097/MOT.0000000000000130
– volume: 99
  start-page: 9864
  year: 2002
  ident: ref_78
  article-title: Characterization of the expression of MHC proteins in human embryonic stem cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.142298299
– volume: 31
  start-page: 2105967
  year: 2021
  ident: ref_51
  article-title: Immune-Modulating Mucin Hydrogel Microdroplets for the Encapsulation of Cell and Microtissue
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.202105967
– volume: 9
  start-page: 6535
  year: 2019
  ident: ref_61
  article-title: Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-42349-w
– volume: 8
  start-page: 355
  year: 1996
  ident: ref_82
  article-title: Role of Fas-mediated cell death in the regulation of immune responses
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/S0952-7915(96)80125-7
– volume: 99
  start-page: 10287
  year: 2002
  ident: ref_84
  article-title: Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.162124199
– volume: 33
  start-page: 2100176
  year: 2021
  ident: ref_123
  article-title: Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
  publication-title: Adv. Mater.
  doi: 10.1002/adma.202100176
– volume: 174
  start-page: 3006
  year: 2005
  ident: ref_118
  article-title: Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.174.5.3006
– volume: 240
  start-page: 119841
  year: 2020
  ident: ref_8
  article-title: A well defect-suitable and high-strength biomimetic squid type II gelatin hydrogel promoted in situ costal cartilage regeneration via dynamic immunomodulation and direct induction manners
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.119841
– volume: 15
  start-page: 1902232
  year: 2019
  ident: ref_121
  article-title: Local immunomodulation using an adhesive hydrogel loaded with miRNA-laden nanoparticles promotes wound healing
  publication-title: Small
  doi: 10.1002/smll.201902232
– volume: 12
  start-page: 100139
  year: 2021
  ident: ref_27
  article-title: Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing
  publication-title: Mater. Today Bio
  doi: 10.1016/j.mtbio.2021.100139
– volume: 61
  start-page: 351
  year: 2018
  ident: ref_53
  article-title: Synthesis and optimization of immunomodulating hydrogel for biomedical application
  publication-title: J. Appl. Biol. Chem.
  doi: 10.3839/jabc.2018.049
– volume: 10
  start-page: 2001239
  year: 2021
  ident: ref_36
  article-title: Recent progress in the design and application of supramolecular peptide hydrogels in cancer therapy
  publication-title: Adv. Healthc. Mater.
  doi: 10.1002/adhm.202001239
– volume: 255
  start-page: 81
  year: 2017
  ident: ref_37
  article-title: Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2017.04.011
– volume: 3
  start-page: 118
  year: 2018
  ident: ref_31
  article-title: DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment
  publication-title: Bioact. Mater.
– volume: 8
  start-page: 2003599
  year: 2021
  ident: ref_43
  article-title: An Insulin-Inspired Supramolecular Hydrogel for Prevention of Type 1 Diabetes
  publication-title: Adv. Sci.
  doi: 10.1002/advs.202003599
– volume: 110
  start-page: 11103
  year: 2013
  ident: ref_35
  article-title: Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1305569110
– volume: 8
  start-page: 1801578
  year: 2019
  ident: ref_87
  article-title: Extracellular matrix-based strategies for immunomodulatory biomaterials engineering
  publication-title: Adv. Healthc. Mater.
  doi: 10.1002/adhm.201801578
– volume: 35
  start-page: 1837
  year: 2018
  ident: ref_44
  article-title: An antifouling hydrogel containing silver nanoparticles for modulating the therapeutic immune response in chronic wound healing
  publication-title: Langmuir
  doi: 10.1021/acs.langmuir.8b01834
– ident: ref_24
  doi: 10.3390/cells9020419
– volume: 220
  start-page: 119403
  year: 2019
  ident: ref_63
  article-title: IFN-γ-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2019.119403
– volume: 2
  start-page: 392
  year: 2019
  ident: ref_96
  article-title: Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-019-0642-9
– volume: 175
  start-page: 3309
  year: 2005
  ident: ref_91
  article-title: α-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.175.5.3309
– volume: 24
  start-page: 500
  year: 2003
  ident: ref_116
  article-title: Herpes and pox viral complement control proteins:‘the mask of self’
  publication-title: Trends Immunol.
  doi: 10.1016/S1471-4906(03)00207-2
– volume: 19
  start-page: 118
  year: 2020
  ident: ref_2
  article-title: Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-019-0462-9
– volume: 268
  start-page: 120549
  year: 2021
  ident: ref_55
  article-title: Biofunctionalization of 3D-printed silicone implants with immunomodulatory hydrogels for controlling the innate immune response: An in vivo model of tracheal defect repair
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.120549
– volume: 61
  start-page: 1474
  year: 2014
  ident: ref_12
  article-title: Hydrogels as carriers for stem cell transplantation
  publication-title: IEEE Trans. Biomed. Eng.
  doi: 10.1109/TBME.2014.2305753
– volume: 14
  start-page: 643
  year: 2015
  ident: ref_86
  article-title: Size-and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates
  publication-title: Nat. Mater.
  doi: 10.1038/nmat4290
– ident: ref_47
  doi: 10.3390/molecules25071539
– volume: 219
  start-page: 155
  year: 2015
  ident: ref_66
  article-title: Controlled release strategies for modulating immune responses to promote tissue regeneration
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2015.08.014
– volume: 155
  start-page: 186
  year: 2018
  ident: ref_89
  article-title: A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens
  publication-title: Immunology
  doi: 10.1111/imm.12972
– volume: 124
  start-page: 179
  year: 2021
  ident: ref_39
  article-title: An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2021.01.041
– volume: 6
  start-page: 26
  year: 2019
  ident: ref_9
  article-title: Toward regeneration of the heart: Bioengineering strategies for immunomodulation
  publication-title: Front. Cardiovasc. Med.
  doi: 10.3389/fcvm.2019.00026
– ident: ref_60
  doi: 10.4018/978-1-7998-1604-1
– volume: 27
  start-page: 470
  year: 2006
  ident: ref_114
  article-title: Pathogen-derived immunomodulatory molecules: Future immunotherapeutics?
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2006.08.002
– volume: 34
  start-page: 470
  year: 2016
  ident: ref_20
  article-title: Engineering immunomodulatory biomaterials to tune the inflammatory response
  publication-title: Trends Biotechnol.
  doi: 10.1016/j.tibtech.2016.03.009
– volume: 378
  start-page: 319
  year: 2011
  ident: ref_108
  article-title: Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: A randomised double-blind trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60895-7
– volume: 36
  start-page: 101049
  year: 2021
  ident: ref_7
  article-title: Tissue adhesives: From research to clinical translation
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2020.101049
– volume: 30
  start-page: 4907
  year: 2009
  ident: ref_18
  article-title: Functional PEG–peptide hydrogels to modulate local inflammation inducedby the pro-inflammatory cytokine TNFα
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.05.083
– volume: 26
  start-page: 6530
  year: 2014
  ident: ref_11
  article-title: Hydrogels and scaffolds for immunomodulation
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201402105
– volume: 10
  start-page: 725
  year: 2020
  ident: ref_64
  article-title: Mesenchymal stem cell-loaded thermosensitive hydroxypropyl chitin hydrogel combined with a three-dimensional-printed poly (ε-caprolactone)/nano-hydroxyapatite scaffold to repair bone defects via osteogenesis, angiogenesis and immunomodulation
  publication-title: Theranostics
  doi: 10.7150/thno.39167
– volume: 8
  start-page: 1676
  year: 2017
  ident: ref_74
  article-title: Langerhans cells—Programmed by the epidermis
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.01676
– volume: 29
  start-page: 1902581
  year: 2019
  ident: ref_34
  article-title: Immune-informed mucin hydrogels evade fibrotic foreign body response in vivo
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201902581
– volume: 3
  start-page: S101
  year: 2008
  ident: ref_67
  article-title: Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result
  publication-title: Clin. J. Am. Soc. Nephrol.
  doi: 10.2215/CJN.03510807
– ident: ref_124
  doi: 10.3390/membranes11090702
– volume: 18
  start-page: e349
  year: 2019
  ident: ref_97
  article-title: A pilot study of the PD-1 targeting agent AMP-224 used with low-dose cyclophosphamide and stereotactic body radiation therapy in patients with metastatic colorectal cancer
  publication-title: Clin. Color. Cancer
  doi: 10.1016/j.clcc.2019.06.004
– volume: 98
  start-page: 86
  year: 2016
  ident: ref_90
  article-title: Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2015.10.020
– volume: 95
  start-page: 499
  year: 2006
  ident: ref_117
  article-title: Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways
  publication-title: Thromb. Haemost.
  doi: 10.1160/TH05-07-0492
– volume: 31
  start-page: 3166
  year: 2010
  ident: ref_83
  article-title: Inducing local T cell apoptosis with anti-Fas-functionalized polymeric coatings fabricated via surface-initiated photopolymerizations
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2010.01.035
– volume: 14
  start-page: 126
  year: 2019
  ident: ref_10
  article-title: Immunomodulatory application of engineered hydrogels in regenerative medicine
  publication-title: Appl. Mater. Today
  doi: 10.1016/j.apmt.2018.11.013
– volume: 20
  start-page: 232
  year: 2022
  ident: ref_102
  article-title: An injectable photo-cross-linking silk hydrogel system augments diabetic wound healing in orthopaedic surgery through spatiotemporal immunomodulation
  publication-title: J. Nanobiotechnol.
  doi: 10.1186/s12951-022-01414-9
– ident: ref_106
  doi: 10.3390/ijms21051598
– volume: 4
  start-page: 379
  year: 2019
  ident: ref_71
  article-title: Macroscale biomaterials strategies for local immunomodulation
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/s41578-019-0106-3
– volume: 12
  start-page: 1092
  year: 2016
  ident: ref_94
  article-title: Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management
  publication-title: Hum. Vaccines Immunother.
  doi: 10.1080/21645515.2015.1129478
– volume: 199
  start-page: 3721
  year: 2017
  ident: ref_76
  article-title: Galectin-1: A jack-of-all-trades in the resolution of acute and chronic inflammation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1701172
– volume: 23
  start-page: 2623
  year: 2017
  ident: ref_65
  article-title: Cell-based tolerogenic therapy, experience from animal models of multiple sclerosis, type 1 diabetes and rheumatoid arthritis
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612823666170214120708
– volume: 121
  start-page: 11305
  year: 2021
  ident: ref_120
  article-title: Immunomodulatory Biomaterials for Tissue Repair
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.0c00895
– volume: 25
  start-page: 492
  year: 2019
  ident: ref_81
  article-title: Harnessing the properties of biomaterial to enhance the immunomodulation of mesenchymal stem cells
  publication-title: Tissue Eng. Part B Rev.
  doi: 10.1089/ten.teb.2019.0131
– volume: 9
  start-page: 7906
  year: 2019
  ident: ref_1
  article-title: Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
  publication-title: Theranostics
  doi: 10.7150/thno.38425
– volume: 17
  start-page: 484
  year: 2018
  ident: ref_52
  article-title: Designing natural and synthetic immune tissues
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-018-0077-6
– volume: 1
  start-page: 16040
  year: 2016
  ident: ref_79
  article-title: Design, clinical translation and immunological response of biomaterials in regenerative medicine
  publication-title: Nat. Rev. Mater.
  doi: 10.1038/natrevmats.2016.40
– volume: 9
  start-page: 21396
  year: 2019
  ident: ref_101
  article-title: The effect of healing phenotype-inducing cytokine formulations within soft hydrogels on encapsulated monocytes and incoming immune cells
  publication-title: RSC Adv.
  doi: 10.1039/C9RA02878A
– volume: 12
  start-page: 126
  year: 2019
  ident: ref_126
  article-title: Delivery strategies of cancer immunotherapy: Recent advances and future perspectives
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0817-3
– volume: 9
  start-page: 135
  year: 2018
  ident: ref_98
  article-title: Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
  publication-title: Protein Cell
  doi: 10.1007/s13238-017-0412-8
– volume: 19
  start-page: 1465
  year: 2013
  ident: ref_75
  article-title: PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes
  publication-title: Tissue Eng. Part A
  doi: 10.1089/ten.tea.2012.0643
– volume: 2020
  start-page: 8868618
  year: 2020
  ident: ref_6
  article-title: Development and In Vivo Characterization of Probiotic Lysate-Treated Chitosan Nanogel as a Novel Biocompatible Formulation for Wound Healing
  publication-title: BioMed Res. Int.
  doi: 10.1155/2020/8868618
– volume: 91
  start-page: 186
  year: 2019
  ident: ref_30
  article-title: Synergistic effects of laminin-1 peptides, VEGF and FGF9 on salivary gland regeneration
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2019.04.049
– ident: ref_72
  doi: 10.1186/1741-7007-10-7
– volume: 8
  start-page: eabd8056
  year: 2022
  ident: ref_13
  article-title: Analyzing immune response to engineered hydrogels by hierarchical clustering of inflammatory cell subsets
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abd8056
– ident: ref_125
  doi: 10.2139/ssrn.3708588
– volume: 6
  start-page: 1614
  year: 2020
  ident: ref_22
  article-title: Macrophage polarization mediated by chitooligosaccharide (COS) and associated osteogenic and angiogenic activities
  publication-title: ACS Biomater. Sci. Eng.
  doi: 10.1021/acsbiomaterials.9b01550
– volume: 19
  start-page: 100608
  year: 2020
  ident: ref_62
  article-title: A biodegradable thermosensitive hydrogel vaccine for cancer immunotherapy
  publication-title: Appl. Mater. Today
  doi: 10.1016/j.apmt.2020.100608
– volume: 24
  start-page: e3415
  year: 2022
  ident: ref_4
  article-title: Histidine-enhanced gene delivery systems: The state of the art
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.3415
– volume: 1079
  start-page: 340
  year: 2006
  ident: ref_107
  article-title: DiaPep277® Preserves Endogenous Insulin Production by Immunomodulation in Type 1 Diabetes
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1196/annals.1375.052
– volume: 4
  start-page: 95
  year: 2021
  ident: ref_28
  article-title: Cell Transplantation Therapies to Reverse Type 1 Diabetes: A review
  publication-title: Abasyn J. Life Sci.
  doi: 10.34091/AJLS.4.1.12
– volume: 30
  start-page: 1902785
  year: 2020
  ident: ref_17
  article-title: Smart injectable hydrogels for cancer immunotherapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201902785
– volume: 30
  start-page: 1217
  year: 2012
  ident: ref_70
  article-title: Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2434
– volume: 1
  start-page: 2000073
  year: 2021
  ident: ref_19
  article-title: Hydrogels for Engineering the Immune System
  publication-title: Adv. Nano Biomed Res.
  doi: 10.1002/anbr.202000073
– volume: 26
  start-page: 649
  year: 2020
  ident: ref_23
  article-title: Mouth-watering results: Clinical need, current approaches, and future directions for salivary gland regeneration
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2020.03.009
SSID ssj0000331839
Score 2.3445125
SecondaryResourceType review_article
Snippet Non-targeted persistent immune activation or suppression by different drug delivery platforms can cause adverse and chronic physiological effects including...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 2244
SubjectTerms Antimitotic agents
Antineoplastic agents
Arthritis
Biodegradable materials
biomaterials
Biomedical materials
Cancer therapies
Chemical properties
Colloids
Cytokines
Diabetes
Dosage and administration
Drug delivery systems
Drugs
Fibroblasts
Foreign bodies
foreign body response
Genotype & phenotype
Glucose
Growth factors
Health aspects
Hydrogels
immune modulation
Immunotherapy
Inflammation
Insulin
Nanoparticles
Osteoarthritis
Pharmaceutical research
Regenerative medicine
Review
Tissue engineering
Transplants & implants
Vehicles
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQTxEoyEioXBqa9SOOjwulWpCK9tBKvVmOH7tI26Tax2H_PTNOursBpF645JCxlXhm7JlJZr4h5KMLTDNb17m2GgIU720OYbPNPZdOltGrmHosXf4sJ9fix428OWj1hTlhHTxwx7gzWZUuBi0s-AKCh6ilrkMRowyxUDoknE-weQfBVDqDOeqq7kp2OMT1Z3fz_SfiFSY3gu0SA2OUMPv_Ppn_zJY8MD8XT8mT3m-k4-59n5FHoXlOTqbd47an9GpfR7U6pSd0uoek3r4gl9-xDKS9bX3q1tXM6GTrl-0MDCO1K4pJvYv1nE6BiE4shQs9X25m9DwsMHFjS8cHP7pfkuuLb1dfJ3nfSCF3EP6t8xgrFriOIJVgg6_BZRg5a7mQHNy70tso_EhCqGorxZVTRShk7T12Hy9KyyN_RY6atgmvCa1rrp1lRc10ENpxq6si-FAIG7kuRzEj4p6jxvUo49jsYmEg2kBBmH8KIiOfd9PuOpiNhyZ8QXHtBiNKdroBumN63TEP6U5GPqGwDe5leEln-5IEWCqiYpmxEiUHl0sVGTkejIQ96Ibke3Ux_RmwMkyxCpOMRjojH3ZknIl5bU1oN2kMuLiVZjIjaqBmg5UNKc2vecIBB35jMdqb_8GKt-Qxw8KOlKZ4TI7Wy014B-7Wun6fdtZvdyAukw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1Nb9Mw1ILuwgXxKQIDeRIal4W5sZ3EJ9SxTQVpU4U2abfI8Uc7qSSlaQ_997yXuu0ypnHJIbaV2O_7-X0Q8tm4RCW6LGOlFRgo1uoYzGYdWy6NTL3NfNtj6eIyHV6LnzfyJjjcmhBWueGJLaO2tUEf-XGSJTmGbPTVt9mfGLtG4e1qaKHxlOwBC87zHtk7Obsc_dp6WRhHnFXr1B0O9v3xbLJzFTcY5AgyTHSEUlu7_18OfT9q8o4YOn9Bngf9kQ7WAH9JnrjqFTkcrT-3OqJXu3yq5oge0tGuNPXqNbn4gekg9e_atl27qjEdruy8HoOApLqhGNw7XUzoCAZRmaXwoKfz5ZieuikGcKzo4M6F9xtyfX529X0Yh4YKsQEzcBF7nyeOKw_QcdrZElSHvtGaC8lBzUut9sL2JZisOs94ZjLmmCytxS7kLNXc87ekV9WVe0doWXJldMLKRDmhDNcqZ846JrTnKu37iIjNiRYmVBvHphfTAqwOBETxICAi8nW7bLYut_G_BScIru1krJbdvqjn4yIQXyHz1HinhAZ9UnDnlVSlY95L51mmHI_IFwR2gTQNP2l0SE2ArWJ1rGKQiZSD6pWxiOx3ZgItmu7wBl2KwAuaYoe5ETnYDuNKjG-rXL1s54Cqm6tERiTroFlnZ92R6nbS1gOH88aktPePf_wDeZZg6kYbiLhPeov50n0EhWpRfgpU8xccsSbJ
  priority: 102
  providerName: ProQuest
Title Immunomodulating Hydrogels as Stealth Platform for Drug Delivery Applications
URI https://www.proquest.com/docview/2728520919
https://www.proquest.com/docview/2729518925
https://pubmed.ncbi.nlm.nih.gov/PMC9610165
https://doaj.org/article/586cfe94a09543ef959be0ff5ef079e3
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfG9sIL4lMERmUkNF6WkcZ2Ej8g1LFNBalThVZpb5Hjj3ZSSUbaSuS_585N2wWGkHjJQ-xTYt9d7nfOfRDyTttYxqooQqkkOCjGqBDcZhUaJrRInEmd77E0ukyGE_71WlzvkU1BhXYDF_e6dthPalLPT37-aD6Bwn9EjxNc9g-3s93p7wLjFsEs8QfkAIxTik0NRi3i9x9nhkIs17k8f6fuWClfzP_PT_bvYZR37NLFY_KoBZR0sJaAJ2TPlk_J0Xj9uOaYXu0SrBbH9IiOd7Wqm2dk9AXzQ6rvlfFtvMopHTamrqZgMalaUIz2nS9ndAyDiG4pXOhZvZrSMzvHiI6GDu78AX9OJhfnV5-HYdthIdTgFy5D57LYMumAXVZZUwCW6GulGBcMcF9ilOOmL8CHVVnKUp1GNhKFMdiWPEoUc-wF2S-r0r4ktCiY1CqOilhaLjVTMoussRFXjsmk7wLCNzua67b8OHbBmOfghiAj8nsZEZCTLdntuv7GvwhOkV3byVg-29-o6mneamMuskQ7K7kCgMmZdVLIwkbOCeuiVFoWkPfI7BzFDl5SqzZXAZaK5bLyQcoTBlgsjQJy2JkJyqm7wxtxyTeyncdpnGH0UV8G5O12GCkx4K201crPAeybyVgEJO2IWWdl3ZHyZuYLhMN-Y5baq_-mfE0expjm4YMWD8n-sl7ZNwC-lkWPHJyeX46_9fzhRc8r1y-qPznp
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbhMx0CrpAS6Ip1goYCQoly517H35gFBKWiW0iSKUSr0tXj8SpLAb8hDKT_GNzGw2SRcQnHrZw469a3tmPDP2PAh5rS2XXGWZL5UEA8UY5YPZrHwjQh1GzsSurLHU60edy-DTVXi1R35uYmHQrXKzJ5YbtSk0npEf85gn6LLRlB-m332sGoW3q5sSGmuyOLerH2Cyzd9324DfN5yfnQ4_dvyqqoCvwRZa-M4l3ArpYIhWWZOB_GxqpUQQCtB1IqNcYJoh2G0qiUWsY2ZZmBmDpbhZpIQT8N1bZD8QEeMNsn9y2h983p7qMIE8ItehQkJIdjwd746m5-hUCTIzqAnBslbAnxLhdy_Na2Lv7B65W-mrtLUmsPtkz-YPyOFg_bvVER3u4rfmR_SQDnapsFcPSa-L4SfFt8KUVcLyEe2szKwYgUCmak7RmXiyGNMBAFF5pvCg7dlyRNt2gg4jK9q6dsH-iFzeyFI_Jo28yO0TQrNMSK04y7i0gdRCyYRZY1mgnJBR03kk2Kxoqqvs5lhkY5KClYOISP-KCI-823abrtN7_K_DCaJr2xizc5cvitkorZg9DZNIOysDBfprIKyTocwscy60jsXSCo-8RWSnuIfAILWqQiFgqpiNK23FQSRA1YuZRw5qLYH3dR28IZe02nvm6Y5TPPJqC8ae6E-X22JZtgHVOpE89EhcI7PazOqQ_Ou4zD8O641BcE___fOX5HZn2LtIL7r982fkDsewkdIJ8oA0FrOlfQ7K3CJ7UXEQJV9umml_AXLvY8Y
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEFcRGGAkGC8Lde3c_IBQR1e1jFUV2qS9ZY4vLVJJSi9C_Wv8Os5J03YBBE97yUNsJ46Pz835zjmEvNaWS66yzJdKgoNijPLBbVa-EaEOI2diV9ZYOhtEvYvg02V4uUd-bmJhEFa5kYmloDaFxjPyJo95gpCNlmy6ChYx7HQ_TL_7WEEK_7Ruymmst8ipXf0A923-vt8BWr_hvHty_rHnVxUGfA1-0cJ3LuFWSAfTtcqaDHRpSyslglCA3RMZ5QLTCsGHU0ksYh0zy8LMGCzLzSIlnIDn3iL7MXpFDbJ_fDIYftme8DCB_CLXYUNCSNacjnfH1HMEWIL-DGoKsawb8Kd2-B2xeU0Fdu-Ru5XtStvrzXaf7Nn8ATkcrl-3OqLnu1iu-RE9pMNdWuzVQ3LWx1CU4lthyoph-Yj2VmZWjEA5UzWnCCyeLMZ0CI1oSFO40M5sOaIdO0HwyIq2r_1sf0QubmSpH5NGXuT2CaFZJqRWnGVc2kBqoWTCrLEsUE7IqOU8EmxWNNVVpnMsuDFJweNBQqR_JYRH3m2HTdepPv434BjJte2MmbrLG8VslFaMn4ZJpJ2VgQJbNhDWyVBmljkXWsdiaYVH3iKxU5QnMEmtqrAI-FTMzJW24yASYPbFzCMHtZ4gB3S9ebNd0koOzdMd13jk1bYZRyK2LrfFsuwDZnYieeiRuLbNal9Wb8m_jstc5LDeGBD39N8vf0luA7Omn_uD02fkDscIkhIPeUAai9nSPge7bpG9qBiIkqub5tlfs0hn-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunomodulating+Hydrogels+as+Stealth+Platform+for+Drug+Delivery+Applications&rft.jtitle=Pharmaceutics&rft.au=Rezaei%2C+Zahra&rft.au=Yilmaz-Aykut%2C+Dilara&rft.au=Tourk%2C+Fatima+Mumtaza&rft.au=Bassous%2C+Nicole&rft.date=2022-10-01&rft.pub=MDPI&rft.eissn=1999-4923&rft.volume=14&rft.issue=10&rft_id=info:doi/10.3390%2Fpharmaceutics14102244&rft.externalDocID=PMC9610165
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon